BMC Formularies by drug class 11.1.12.xlsx - BMC HealthNet Plan

More documents

Recommendations

Info

AHFS Therapeutic Class Description Product Name Multi‐Source Code Formulary Tier Prior Auth Required Quantity Limits Specialty Product Formulary StatusOPIATE AGONISTS DILAUDID INJ 2MG/ML Brand‐O TIER 03 PADILAUDID INJ 4MG/ML Brand‐O TIER 03 PADILAUDID TAB 2MG Brand‐O TIER 03 PADILAUDID TAB 4MG Brand‐O TIER 03 PADILAUDID TAB 8MG Brand‐O TIER 03 PADILAUDID‐5 LIQ 1MG/ML Brand‐O TIER 03 PADILAUDID‐HP INJ 10MG/ML Brand‐O TIER 03 PADILAUDID‐HP INJ 250MG BRAND TIER 03DOLOPHINE TAB 10MG Brand‐O TIER 03 PADOLOPHINE TAB 5MG Brand‐O TIER 03 PADURAGESIC DIS 100MCG/H Brand‐O TIER 03 PA QLDURAGESIC DIS 12MCG/HR Brand‐O TIER 03 PA QLDURAGESIC DIS 25MCG/HR Brand‐O TIER 03 PA QLDURAGESIC DIS 50MCG/HR Brand‐O TIER 03 PA QLDURAGESIC DIS 75MCG/HR Brand‐O TIER 03 PA QLDURAMORPH INJ 0.5MG/ML GENERIC TIER 01DURAMORPH INJ 1MG/ML GENERIC TIER 01ENDOCET TAB 10‐325MG GENERIC TIER 01 QLENDOCET TAB 10‐650MG GENERIC TIER 01 QLENDOCET TAB 5‐325MG GENERIC TIER 01 QLENDOCET TAB 7.5‐325M GENERIC TIER 01 QLENDOCET TAB 7.5‐500M GENERIC TIER 01 QLENDODAN TAB GENERIC TIER 01 QLEXALGO TAB 12MG BRAND TIER 03 PA QLEXALGO TAB 16MG BRAND TIER 03 PA QLEXALGO TAB 32MG BRAND TIER 03 PAEXALGO TAB 8MG BRAND TIER 03 PA QLFENTANYL DIS 100MCG/H GENERIC TIER 01 QLFENTANYL DIS 12MCG/HR GENERIC TIER 01 QLFENTANYL DIS 25MCG/HR GENERIC TIER 01 QLFENTANYL DIS 50MCG/HR GENERIC TIER 01 QLFENTANYL DIS 75MCG/HR GENERIC TIER 01 QLFENTANYL CIT INJ 0.05MG/1 GENERIC TIER 01 PAFENTANYL CIT INJ 1000MCG GENERIC TIER 01 PAFENTANYL CIT INJ 100MCG GENERIC TIER 01 PAFENTANYL CIT INJ 2500MCG GENERIC TIER 01 PAFENTANYL CIT INJ 250MCG GENERIC TIER 01 PAFENTANYL OT LOZ 1200MCG GENERIC TIER 01 PA QLFENTANYL OT LOZ 1600MCG GENERIC TIER 01 PA QLKey: Brand‐O = Brand with AB‐rated generic equivalent. Coverage Detail: PA=Prior Authorization, SP= Restricted to specialty pharmacy, QL= Quantity Limit, MO= Mail order eligible after one prescription fill at retail, DE= DrugExclusion198
AHFS Therapeutic Class Description Product Name Multi‐Source Code Formulary Tier Prior Auth Required Quantity Limits Specialty Product Formulary StatusOPIATE AGONISTS FENTANYL OT LOZ 200MCG GENERIC TIER 01 PA QLFENTANYL OT LOZ 400MCG GENERIC TIER 01 PA QLFENTANYL OT LOZ 600MCG GENERIC TIER 01 PA QLFENTANYL OT LOZ 800MCG GENERIC TIER 01 PA QLFENTORA TAB 100MCG BRAND TIER 02 PA QLFENTORA TAB 200MCG BRAND TIER 02 PA QLFENTORA TAB 400MCG BRAND TIER 02 PA QLFENTORA TAB 600MCG BRAND TIER 02 PA QLFENTORA TAB 800MCG BRAND TIER 02 PA QLFIORICET/COD CAP Brand‐O TIER 03 PAFIORINAL/COD CAP 30MG Brand‐O TIER 03 PAHYCET SOL 7.5‐325 Brand‐O TIER 03 PAHYDROCO/APAP SOL 10‐325MG GENERIC TIER 01HYDROCO/APAP SOL 7.5‐325 GENERIC TIER 01HYDROCO/APAP SOL 7.5‐500 GENERIC TIER 01HYDROCO/APAP TAB 10‐300MG GENERIC TIER 01HYDROCO/APAP TAB 10‐325MG GENERIC TIER 01HYDROCO/APAP TAB 10‐500MG GENERIC TIER 01HYDROCO/APAP TAB 10‐650MG GENERIC TIER 01HYDROCO/APAP TAB 10‐660MG GENERIC TIER 01HYDROCO/APAP TAB 10‐750MG GENERIC TIER 01HYDROCO/APAP TAB 2.5‐325 GENERIC TIER 01HYDROCO/APAP TAB 2.5‐500 GENERIC TIER 01HYDROCO/APAP TAB 5‐300MG GENERIC TIER 01HYDROCO/APAP TAB 5‐325MG GENERIC TIER 01HYDROCO/APAP TAB 5‐500MG GENERIC TIER 01HYDROCO/APAP TAB 7.5‐300 GENERIC TIER 01HYDROCO/APAP TAB 7.5‐325 GENERIC TIER 01HYDROCO/APAP TAB 7.5‐500 GENERIC TIER 01HYDROCO/APAP TAB 7.5‐650 GENERIC TIER 01HYDROCO/APAP TAB 7.5‐750 GENERIC TIER 01HYDROCOD/IBU TAB 10‐200MG GENERIC TIER 01HYDROCOD/IBU TAB 2.5‐200 GENERIC TIER 01HYDROCOD/IBU TAB 5‐200MG GENERIC TIER 01HYDROCOD/IBU TAB 7.5‐200 GENERIC TIER 01HYDROCODONE CRY BITARTRA GENERIC TIER 99 DEHYDROGESIC CAP 5‐500MG GENERIC TIER 01HYDROMORPHON INJ 10MG/ML GENERIC TIER 01HYDROMORPHON INJ 1MG/ML GENERIC TIER 01Key: Brand‐O = Brand with AB‐rated generic equivalent. Coverage Detail: PA=Prior Authorization, SP= Restricted to specialty pharmacy, QL= Quantity Limit, MO= Mail order eligible after one prescription fill at retail, DE= DrugExclusion199
Page 1 and 2:
BMC HealthNet Plan Drug List - Comm
Page 3 and 4:
AHFS Therapeutic Class Description
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149: AHFS Therapeutic Class Description
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280:
show all

BMC Formularies by drug class 11.1.12.xlsx - BMC HealthNet Plan

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?